pillbase.ru

Tizveni

Active substance: tislelizumab

tislelizumab

Centralised EU authorisationWithdrawn

Marketing holder: BeiGene Ireland Ltd

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • TEVIMBRA
    INJECTION, SOLUTION, CONCENTRATE · TISLELIZUMAB 10 mg/mL
    72579-121
    BeOne Medicines USA, Inc.
  • TEVIMBRA
    INJECTION, SOLUTION, CONCENTRATE · TISLELIZUMAB 10 mg/mL
    72579-125
    BeOne Medicines USA, Inc.
  • tislelizumab-jsgr
    INJECTION, SOLUTION, CONCENTRATE · TISLELIZUMAB 10 mg/mL
    17088-0378
    Novartis Pharma Stein AG
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-67ad-7892-befb-942975ab0858,01a12095-1861-76ae-82bf-b6f398938bf3,01a1209e-68c9-7302-9c25-c4255d775aa5;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005542
Registration status
Withdrawn
ATC code
L01FF09
Sources
  • product · EMA · EMEA/H/C/005542 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005542 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005542 · Verified 2026-10-09